J. Biochem, 2004, Vol. 135, No. 5 577-582
© 2004 The Japanese Biochemical Society
BIOTECHNOLOGY |
Preparation of Recombinant
-Thrombin: High-Level Expression of Recombinant Human Prethrombin-2 and Its Activation by Recombinant Ecarin
,21 Applied Research Department and 2 First Research Department, The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN), Kawabe, Kyokushi, Kikuchi, Kumamoto 869-1298
We have established a large-scale manufacturing system to produce recombinant human
-thrombin. In this system, a high yield of
-thrombin is prepared from prethrombin-2 activated by recombinant ecarin. We produced human prethrombin-2 using mouse myeloma cells and an expression plasmid carrying the chicken ß-actin promoter and mutant dihydrofolate reductase gene for gene amplification. To increase prethrombin-2 expression further, we performed fed-batch cultivation with the addition of vegetable peptone in 50 liters of suspension culture. After five feedings of vegetable peptone, the expression level of the recombinant prethrombin-2 reached 200 µg/ml. Subsequently, the recombinant prethrombin-2 could be activated to
-thrombin by recombinant ecarin expressed in a similar manner. Finally, recombinant
-thrombin was purified to homogeneity by affinity chromatography using a benzamidine-Sepharose gel. The yield from prethrombin-2 in culture medium was approximately 70%. The activity of the purified recombinant
-thrombin, including hydrolysis of a chromogenic substrate, release of fibrinopeptide A, and activation of protein C, was indistinguishable from that of plasma-derived
-thrombin. Our system is suitable for the large-scale production of recombinant
-thrombin, which can be used in place of clinically available
-thrombin derived from human or bovine plasma.
* These authors contributed equally to this work.
To whom correspondence should be addressed. Tel: +81-968-37-3100, Fax: +81-968-37-3616, E-mail: nozaki{at}kaketsuken.or.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Terrab, D. Pawlak, P. Spaay, D. Hoppensteadt, and J. Fareed Further Removal of Factor V Related Antigen From Bovine Thrombin by Utilizing a Membrane-Filtration Step Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 135 - 140. [Abstract] [PDF] |
||||
![]() |
C. Y. Koh, M. Kazimirova, A. Trimnell, P. Takac, M. Labuda, P. A. Nuttall, and R. M. Kini Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick J. Biol. Chem., October 5, 2007; 282(40): 29101 - 29113. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Soejima, H. Nakamura, M. Hirashima, W. Morikawa, C. Nozaki, and T. Nakagaki Analysis on the Molecular Species and Concentration of Circulating ADAMTS13 in Blood J. Biochem., January 1, 2006; 139(1): 147 - 154. [Abstract] [Full Text] [PDF] |
||||


